You are viewing the site in preview mode

Skip to main content

Advertisement

Table 3 Dose-limiting toxicity

From: Phase I study of neoadjuvant chemoradiotherapy with S-1 plus biweekly cisplatin for advanced gastric cancer patients with lymph node metastasis: -KOGC04-

n = 9 Level 1 Level 2** Level 3*
Hematological toxicity 0 0 0
Nonhematological toxicity 0 0 2
Treatment delay 0 0 0
  1. *: Maximum tolerated dose, **: Recommended dose.